# Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-abrocitinib-in-adults-and-adolescents-with-moderate-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eric L. Simpson,Rodney Sinclair,Seth Forman,Andreas Wollenberg,Roland Aschoff,Michael J. Cork,Thomas Bieber,Jacob P. Thyssen,Gil Yosipovitch,Carsten Flohr,Nina Magnolo,Catherine Maari,Claire Feeney,Pinaki Biswas,Svitlana Tatulych,Hernán Valdez,Ricardo Rojo |
| Citations | 505 |
| DOI | 10.1016/s0140-6736(20)30732-7 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://researchprofiles.ku.dk/da/publications/f837e799-f74e-4666-a7fc-0ec6543a5997 |
| OpenAlex ID | https://openalex.org/W3044651017 |
| PMID | 32711801 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Andreas Wollenberg](https://scholariq.org/researchers/andreas-wollenberg/)
- [Jacob P. Thyssen](https://scholariq.org/researchers/jacob-p-thyssen/)
- [Thomas Bieber](https://scholariq.org/researchers/thomas-bieber/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.